Earnings analysis · 10-Q
DOC earnings analysis
Filed May 6, 2026 · Our reading of the company's report
The latest report
Healthpeak Properties, Inc. delivered a strong Q1 2026 performance with revenue reaching $752.95 million, which was a notable increase of 9.5% from the estimated revenue while EPS surpassed expectations at $0.45…
Read full summary
Healthpeak Properties, Inc. delivered a strong Q1 2026 performance with revenue reaching $752.95 million, which was a notable increase of 9.5% from the estimated revenue while EPS surpassed expectations at $0.45 compared to a loss of $0.17 in the same quarter last year. Management highlighted positive trends from recent acquisitions and an IPO, indicating solid growth prospects moving forward.
Reported figures
- Earnings per share
- $0.45
- Segment
- Outpatient Medical
- Segment
- Lab
- Segment
- Senior Housing
What stood out
-
Revenue Growth Exceeds Estimates
Reported revenue for Q1 2026 was $752.95 million, 9.5% higher than the estimated $688.89 million.
-
Earnings Per Share Beat Expectations
EPS for Q1 2026 was $0.45, exceeding the estimated $0.43 and a significant increase from $0.06 in Q1 2025.
-
Significant Increase in Net Income
Net income applicable to common shares rose to $193.48 million from $42.36 million YoY.
-
Strong Performance in Outpatient Medical Segment
Outpatient medical Adjusted NOI increased by 2.4%, contributing $186.84 million.
-
Successful Janus Living IPO Contribution
Janus Living IPO generated gross proceeds of $966 million, enhancing liquidity and growth potential.
-
Improved Senior Housing Performance
Senior housing Adjusted NOI increased by 13.8%, reaching $55.43 million due to increased resident fees.
What to watch
-
Increased Interest Expense
Interest expense rose to $87.29 million from $72.69 million, straining profitability due to higher borrowings.
-
Decreased NOI from Lab Sector
Lab Adjusted NOI decreased by 7.2% to $112.94 million, primarily due to lower occupancy.
-
Transaction Costs Related to IPO
Transaction costs surged to $24.15 million from $5.53 million, impacting overall expenses significantly.
Management's outlook
Management anticipates FY 2026 diluted EPS in the range of $0.46 to $0.50, up from prior guidance.
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.